Prognostic and diagnostic value of spontaneous tumor-related antibodies

Clinical and Developmental Immunology

Volumn 2010, Issue , 2010, Pages

  Kobold, Sebastian ^a   Luetkens, Tim ^a   Cao, Yanran ^a   Bokemeyer, Carsten ^a   Atanackovic, Djordje ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CANCER ANTIBODY; TUMOR ANTIGEN; DIAGNOSTIC AGENT;

ANTIBODY SPECIFICITY; CANCER DIAGNOSIS; CANCER RELAPSE; CANCER RISK; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; BLOOD; IMMUNOLOGY; NEOPLASM;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; AUTOANTIBODIES; HUMANS; NEOPLASMS; PROGNOSIS;

EID: 79952216352     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2010/721531     Document Type: Review

References (88)

1. Silberstein A. M., History of Immunology 1989 San Diego, Calif, USA Academic Press
2. Bui J. D., Schreiber R. D., Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? (Pubitemid 46356963)
3. Willimsky G., Blankenstein T., Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance Nature 2005 437 7055 141 146 (Pubitemid 41613441)
4. Bei R., Masuelli L., Palumbo C., Modesti M., Modesti A., A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: inflammation in their induction and impact on tumor growth Cancer Letters 2009 281 1 8 23
5. Black M. M., Kerpe S., Speer F. D., Lymph node structure in patients with cancer of the breast American Journal of Pathology 1953 29 505 521
6. Ralhan R., Nath N., Agarwal S., Mathur M., Wasylyk B., Shukla N. K., Circulating p53 antibodies as early markers of oral cancer: correlation with p53 alterations Clinical Cancer Research 1998 4 9 2147 2152 (Pubitemid 28415661)
7. Tan H. T., Low J., Lim S. G., Chung M. C. M., Serum autoantibodies as biomarkers for early cancer detection FEBS Journal 2009 276 23 6880 6904
8. Lubin R., Zalcman G., Bouchet L., Tredaniel J., Legros Y., Cazals D., Hirsch A., Soussi T., Serum p53 antibodies as early markers of lung cancer Nature Medicine 1995 1 7 701 702
9. DeNardo D. G., Coussens L. M., Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression Breast Cancer Research 2007 9 4 212
10. Titulaer M. J., Klooster R., Potman M., Sabater L., Graus F., Hegeman I. M., Thijssen P. E., Wirtz P. W., Twijnstra A., Sillevis Smitt P. A. E., Van Der Maarel S., Verschuuren J. J. G. M., SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: frequency and relation with survival Journal of Clinical Oncology 2009 27 26 4260 4267
11. Ait-Tahar K., Damm-Welk C., Burkhardt B., Zimmermann M., Klapper W., Reiter A., Pulford K., Woessmann W., Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk Blood 2010 115 16 3314 3319
12. Lu H., Goodell V., Disis M. L., Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer Journal of Proteome Research 2008 7 4 1388 1394
13. Research LIfC, Cancer Immunome Database. 2010
14. Preuss K. D., Zwick C., Bormann C., Neumann F., Pfreundschuh M., Analysis of the B-cell repertoire against antigens expressed by human neoplasms Immunological Reviews 2002 188 43 50 (Pubitemid 35398864)
15. Von Mensdorff-Pouilly S., Gourevitch M. M., Kenemans P., Verstraeten A. A., Litvinov S. V., Van Kamp G. J., Meijer S., Vermorken J., Hilgers J., Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours European Journal of Cancer A 1996 32 8 1325 1331 (Pubitemid 26246705)
16. Nakamura H., Hinoda Y., Nakagawa N., Makiguchi Y., Itoh F., Endo T., Imai K., Detection of circulating anti-MUC1 mucin core protein antibodies in patients with colorectal cancer Journal of Gastroenterology 1998 33 3 354 361 (Pubitemid 28263650)
17. Chapman C., Murray A., Chakrabarti J., Thorpe A., Woolston C., Sahin U., Barnes A., Robertson J., Autoantibodies in breast cancer: their use as an aid to early diagnosis Annals of Oncology 2007 18 5 868 873 (Pubitemid 47054083)
18. Hirasawa Y., Kohno N., Yokoyama A., Kondo K., Hiwada K., Miyake M., Natural autoantibody to MUC1 is a prognostic indicator for non-small cell lung cancer American Journal of Respiratory and Critical Care Medicine 2000 161 2 I 589 594 (Pubitemid 30129471)
19. Lubin R., Schlichtholz B., Teillaud J. L., Garay E., Bussel A., Wild C. P., Soussi T., p53 antibodies in patients with various types of cancer: assay, identification, and characterization Clinical Cancer Research 1995 1 12 1463 1469 (Pubitemid 26028081)
20. Lubin R., Schlichtholz B., Bengoufa D., Zalcman G., Tredaniel J., Hirsch A., De Fromentel C. C., Preudhomme C., Fenaux P., Fournier G., Mangin P., Laurent-Puig P., Pelletier G., Schlumberger M., Desgrandchamps F., Le Duc A., Peyrat J. P., Janin N., Bressac B., Soussi T., Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface Cancer Research 1993 53 24 5872 5876 (Pubitemid 24006152)
21. Ralhan R., Arora S., Chattopadhyay T. K., Shukla N. K., Mathur M., Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India International Journal of Cancer 2000 85 6 791 795 (Pubitemid 30131467)
22. Zhang J. Y., Casiano C. A., Peng X. X., Koziol J. A., Chan E. K. L., Tan E. M., Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens Cancer Epidemiology Biomarkers and Prevention 2003 12 2 136 143 (Pubitemid 36194003)
23. Abendstein B., Marth C., Mller-Holzner E., Widschwendter M., Daxenbichler G., Zeimet A. G., Clinical significance of serum and ascitic p53 autoantibodies in epithelial ovarian carcinoma Cancer 2000 88 6 1432 1437 (Pubitemid 30155182)
24. Vogl F. D., Stickeler E., Weyermann M., Khler T., Grill H. J., Negri G., Kreienberg R., Runnebaum I. B., p53 autoantibodies in patients with primary ovarian cancer are associated with higher age, advanced stage and a higher proportion of p53-positive tumor cells Oncology 1999 57 4 324 329
25. Tschernatsch M., Gross O., Kneifel N., Kaps M., Blaes F., SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes Autoimmunity Reviews 2009 8 7 549 551
26. Davis T. M. E., Mehta Z., Mackay I. R., Cull C. A., Bruce D. G., Fida S., Rowley M. J., Holman R. R., Autoantibodies to the islet cell antigen SOX-13 are associated with duration but not type of diabetes Diabetic Medicine 2003 20 3 198 204 (Pubitemid 36390734)
27. Li S., Deng Y., Li XI., Chen Q. P., Liao X. C., Qin X., Diagnostic value of Epstein-Barr virus capsid antigen-IgA in nasopharyngeal carcinoma: a meta-analysis Chinese Medical Journal 2010 123 9 1201 1205
28. Babel I., Barderas R., Daz-Uriarte R., Martnez-Torrecuadrada J. L., Snchez-Carbayo M., Casal J. I., Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays Molecular and Cellular Proteomics 2009 8 10 2382 2395
29. Zhong L., Ge K., Zu J. C., Zhao L. H., Shen W. K., Wang J. F., Zhang X. G., Gao X., Hu W., Yen Y., Kernstine K. H., Autoantibodies as potential biomarkers for breast cancer Breast Cancer Research 2008 10 3 R40
30. Desmetz C., Bascoul-Mollevi C., Rochaix P., Lamy P. J., Kramar A., Rouanet P., Maudelonde T., Mang A., Solassol J., Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women Clinical Cancer Research 2009 15 14 4733 4741
31. Chen X., Fu S., Chen F., Chen H., Chen Z., Identification of tumor-associated antigens in human hepatocellular carcinoma by autoantibodies Oncology Reports 2008 20 4 979 985
32. Chan C. C., Fan C. W., Kuo Y. B., Chen YU. H., Chang PI. Y., Chen K. T., Hung R. P., Chan E. C., Multiple serological biomarkers for colorectal cancer detection International Journal of Cancer 2010 126 7 1683 1690
33. Ran Y., Hu H., Zhou Z., Yu L., Sun L., Pan J., Liu J., Yang Z., Profiling tumor-associated autoantibodies for the detection of colon cancer Clinical Cancer Research 2008 14 9 2696 2700
34. Chen Y., Zhou Y., Qiu S., Wang K., Liu S., Peng X. X., Li J., Tan E. M., Zhang J. Y., Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma Cancer Letters 2010 289 1 32 39
35. Zhang J. Y., Megliorino R., Peng X. X., Tan E. M., Chen Y., Chan E. K. L., Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma Journal of Hepatology 2007 46 1 107 114 (Pubitemid 44827418)
36. Lin HO. S., Talwar H. S., Tarca A. L., Ionan A., Chatterjee M., Ye B., Wojciechowski J., Mohapatra S., Basson M. D., Yoo G. H., Peshek B., Lonardo F., Pan C. J. G., Folbe A. J., Draghici S., Abrams J., Tainsky M. A., Autoantibody approach for serum-based detection of head and neck cancer Cancer Epidemiology Biomarkers and Prevention 2007 16 11 2396 2405 (Pubitemid 351196373)
37. Wandall H. H., Blixt O., Tarp M. A., Pedersen J. W., Bennett E. P., Mandel U., Ragupathi G., Livingston P. O., Hollingsworth M. A., Taylor-Papadimitriou J., Burchell J., Clausen H., Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes Cancer Research 2010 70 4 1306 1313
38. Taylor D. D., Gercel-Taylor C., Parker L. P., Patient-derived tumor-reactive antibodies as diagnostic markers for ovarian cancer Gynecologic Oncology 2009 115 1 112 120
39. Patwa T. H., Li C., Poisson L. M., Kim H. Y., Pal M., Ghosh D., Simeone D. M., Lubman D. M., The identification of phosphoglycerate kinase-1 and histone H4 autoantibodies in pancreatic cancer patient serum using a natural protein microarray Electrophoresis 2009 30 12 2215 2226
40. Wang X., Yu J., Sreekumar A., Varambally S., Shen R., Giacherio D., Mehra R., Montie J. E., Pienta K. J., Sanda M. G., Kantoff P. W., Rubin M. A., Wei J. T., Ghosh D., Chinnaiyan A. M., Autoantibody signatures in prostate cancer New England Journal of Medicine 2005 353 12 1224 1235 (Pubitemid 41345944)
41. Murray A., Chapman C. J., Healey G., Peek L. J., Parsons G., Baldwin D., Barnes A., Sewell H. F., Fritsche H. A., Robertson J. F.R., Technical validation of an autoantibody test for lung cancer Annals of Oncology 2010 21 8 1687 1693
42. Honda H., Kusumoto S., Nishikawa K., Hoshi H., Jinnouchi S., Kodama T., Koga K., Wakuta Y., Nakayama S., Kakitsubata Y., Watanabe K., Limitation of CT in diagnosis of pancreatic cancer Radiation Medicine-Medical Imaging and Radiation Oncology 1991 9 2 61 67
43. Fagiolo U., Amadori A., Biselli R., Paganelli R., Nisini R., Cozzi E., Zamarchi R., D'Amelio R., Quantitative and qualitative analysis of anti-tetanus toxoid antibody response in the elderly. Humoral immune response enhancement by thymostimulin Vaccine 1993 11 13 1336 1340 (Pubitemid 23319662)
44. Barbouche M. R., Romain S., Avrameas S. A., Piana L., Martin P. M., Prognostic significance of autoantibodies to laminin in the sera of breast cancer patients: a preliminary report European Journal of Clinical Chemistry and Clinical Biochemistry 1994 32 7 511 514 (Pubitemid 24229867)
45. Conroy S. E., Faulds G. B., Williams W., Latchman D. S., Isenberg D. A., Detection of autoantibodies to the 90 kDa head shock protein in systemic lupus erythematosus and other autoimmune diseases British Journal of Rheumatology 1994 33 10 923 926 (Pubitemid 24324806)
46. Soussi T., p53 Antibodies in the sera of patients with various types of cancer: a review Cancer Research 2000 60 7 1777 1788 (Pubitemid 30207629)
47. Foss A., Berner A., Foss S. D., Hernes E., Gaudernack G., Smeland E. B., NY-ESO-I protein expression and humoral immune responses in prostate cancer Prostate 2004 59 4 440 447 (Pubitemid 38661812)
48. Brankin B., Skaar T. C., Brotzman M., Trock B., Clarke R., Autoantibodies to the nucleolar phosphoprotein nucleophosmin in breast cancer patients Cancer Epidemiology Biomarkers and Prevention 1998 7 12 1109 1115 (Pubitemid 29001667)
49. Gnjatic S., Ritter E., Bchler M. W., Giese N. A., Brors B., Frei C., Murray A., Halama N., Zrnig I., Chen Y. T., Andrews C., Ritter G., Old L. J., Odunsi K., Jger D., Seromic profiling of ovarian and pancreatic cancer Proceedings of the National Academy of Sciences of the United States of America 2010 107 11 5088 5093
50. Parmigiani R. B., Bettoni F., Grosso D. M., Lopes A., Cunha I. W., Soares F. A., Carvalho A. L., Fonseca F., Camargo A. A., Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical-recurrence International Journal of Cancer 2008 122 10 2385 2390 (Pubitemid 351542347)
51. Saffroy R., Lelong J. C., Azoulay D., Salvucci M., Reynes M., Bismuth H., Debuire B., Lemoine A., Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma British Journal of Cancer 1999 79 3-4 604 610 (Pubitemid 29046243)
52. Friedrichs B., Siegel S., Kloess M., Barsoum A., Coggin J., Rohrer J., Jakob I., Tiemann M., Heidorn K., Schulte C., Kabelitz D., Steinmann J., Schmitz N., Zeis M., Humoral immune responses against the immature laminin receptor protein show prognostic significance in patients with chronic lymphocytic leukemia Journal of Immunology 2008 180 9 6374 6384
53. Yang X. F., Wu C. J., McLaughlin S., Chillemi A., Wang K. S., Canning C., Alyea E. P., Kantoff P., Soiffer R. J., Dranoff G., Ritz J., CML66, a broadly immunogenic tumor antigen, elicits a humoral immune response associated with remission of chronic myelogenous leukemia Proceedings of the National Academy of Sciences of the United States of America 2001 98 13 7492 7497 (Pubitemid 32567976)
54. Pallasch C. P., Struss A. K., Munnia A., Knig J., Steudel W. I., Fischer U., Meese E., Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival International Journal of Cancer 2005 117 3 456 459 (Pubitemid 41429569)
55. Richards E. R., Devine P. L., Quin R. J., Fontenot J. D., Ward B. G., McGuckin M. A., Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women Cancer Immunology Immunotherapy 1998 46 5 245 252 (Pubitemid 28332922)
56. Kocer B., McKolanis J., Soran A., Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma BMC Gastroenterology 2006 6, article 4
57. Vural B., Chen L. C., Saip P., Chen Y. T., Ustuner Z., Gonen M., Simpson A. J. G., Old L. J., Ozbek U., Gure A. O., Frequency of SOX group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters Cancer 2005 103 12 2575 2583 (Pubitemid 40800537)
58. Haidopoulos D., Konstadoulakis M. M., Antonakis P. T., Alexiou D. G., Manouras A. M., Katsaragakis S. M., Androulakis G. F., Circulating anti-CEA antibodies in the sera of patients with breast cancer European Journal of Surgical Oncology 2000 26 8 742 746 (Pubitemid 32059830)
59. Comtesse N., Zippel A., Walle S., Monz D., Backes C., Fischer U., Mayer J., Ludwig N., Hildebrandt A., Keller A., Steudel W. I., Lenhof H. P., Meese E., Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets Proceedings of the National Academy of Sciences of the United States of America 2005 102 27 9601 9606 (Pubitemid 40981727)
60. Wadle A., Kubuschok B., Imig J., Wuellner B., Wittig C., Zwick C., Mischo A., Waetzig K., Romeike B. F. M., Lindemann W., Schilling M., Pfreundschuh M., Renner C., Serological immune response to cancer testis antigens in patients with pancreatic cancer International Journal of Cancer 2006 119 1 117 125
61. Ersvaer E., Zhang J. Y., McCormack E., Olsnes A., nensen N., Tan E. M., Gjertsen B. T., Bruserud., Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients European Journal of Haematology 2007 79 3 210 225 (Pubitemid 47231163)
62. Vidal C. I., Mintz P. J., Lu K., Ellis L. M., Manenti L., Giavazzi R., Gershenson D. M., Broaddus R., Liu J., Arap W., Pasqualini R., An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients Oncogene 2004 23 55 8859 8867 (Pubitemid 39657776)
63. Mussolin L., Bonvini P., Ait-Tahar K., Pillon M., Tridello G., Buffardi S., Lombardi A., Pulford K., Rosolen A., Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL Leukemia 2009 23 2 400 402
64. Diesinger I., Bauer C., Brass N., Schaefers H. J., Comtesse N., Sybrecht G., Meese E., Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma International Journal of Cancer 2002 102 4 372 378 (Pubitemid 35265878)
65. Hermsen B. B. J., Verheijen R. H. M., Menko F. H., Gille J. J. P., van Uffelen K., Blankenstein M. A., Meijer S., van Diest P. J., Kenemans P., von Mensdorff-Pouilly S., Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation European Journal of Cancer 2007 43 10 1556 1563 (Pubitemid 46891805)
66. Karanikas V., Khalil S., Kerenidi T., Gourgoulianis K. I., Germenis A. E., Anti-survivin antibody responses in lung cancer Cancer Letters 2009 282 2 159 166
67. Jger E., Srockert E., Zidianakis Z., Cnen Y. T., Karbach J., Jger D., Arand M., Ritter G., Old L. J., Knuth A., Humoral immune responses of cancer patients against "cancer-testis" antigen NY-ESO-1: correlation with clinical events International Journal of Cancer 1999 84 5 506 510
68. Akcakanat A., Kanda T., Koyama YU., Watanabe M., Kimura E., Yoshida Y., Komukai S., Nakagawa S., Odani S., Fujii H., Hatakeyama K., NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer Cancer Chemotherapy and Pharmacology 2004 54 1 95 100 (Pubitemid 38858372)
69. Pavoni E., Pucci A., Vaccaro P., Monteri G., Ceratti A. D. P., Lugini A., Virdis R. A., Cortesi E., De Gaetano A., Panunzi S., Felici F., Minenkova O., A study of the humoral immune response of breast cancer patients to a panel of human tumor antigens identified by phage display Cancer Detection and Prevention 2006 30 3 248 256 (Pubitemid 44163059)
70. Fensterle J., Becker J. C., Potapenko T., Heimbach V., Vetter C. S., Brcker E. B., Rapp U. R., B-Raf specific antibody responses in melanoma patients BMC Cancer 2004 4, article 62
71. Angelopoulou K., Stratis M., Diamandis E. P., Humoral immune response against p53 protein in patients with colorectal carcinoma International Journal of Cancer 1997 70 1 46 51 (Pubitemid 27059704)
72. Tangkijvanich P., Janchai A., Charuruks N., Kullavanijaya P., Theamboonlers A., Hirsch P., Poovorawan Y., Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma Asian Pacific Journal of Allergy and Immunology 2000 18 4 237 243 (Pubitemid 32249033)
73. Tang R., Ko M. C., Wang J. Y., Changchien C. R., Chen H. H., Chen J. S., Hsu K. C., Chiang JY. M., Hsieh L. L., Humoral response to p53 in human colorectal tumors: a prospective study of 1,209 patients International Journal of Cancer 2001 94 6 859 863 (Pubitemid 33032835)
74. Maio M., Coral S., Sigalotti L., Elisei R., Romei C., Rossi G., Cortini E., Colizzi F., Fenzi G., Altomonte M., Pinchera A., Vitale M., Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1 Journal of Clinical Endocrinology and Metabolism 2003 88 2 748 754 (Pubitemid 36207818)
75. Van Rhee F., Szmania S. M., Zhan F., Gupta S. K., Pomtree M., Lin P., Batchu R. B., Moreno A., Spagnoli G., Shaughnessy J., Tricot G., NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses Blood 2005 105 10 3939 3944 (Pubitemid 40656140)
76. DiFronzo L. A., Gupta R. K., Essner R., Foshag L. J., O'Day S. J., Wanek L. A., Stern S. L., Morton D. L., Enhanced humoral immune response correlates with improved disease-free and overall survival in American Joint Committee on cancer stage II melanoma patients receiving adjuvant polyvalent vaccine Journal of Clinical Oncology 2002 20 15 3242 3248 (Pubitemid 34831521)
77. Dickersin K., The existence of publication bias and risk factors for its occurrence Journal of the American Medical Association 1990 263 10 1385 1389 (Pubitemid 20069945)
78. Valmori D., Souleimanian N. E., Tosello V., Bhardwaj N., Adams S., O'Neill D., Pavlick A., Escalon J. B., Cruz C. M., Angiulli A., Angiulli F., Mears G., Vogel S. M., Pan L., Jungbluth A. A., Hoffmann E. W., Venhaus R., Ritter G., Old L. J., Ayyoub M., Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-priming Proceedings of the National Academy of Sciences of the United States of America 2007 104 21 8947 8952 (Pubitemid 47175417)
79. Lieberman D., Progress and challenges in colorectal cancer screening and surveillance Gastroenterology 2010 138 6 2115 2126
80. O'Shaughnessy M., Konety B., Warlick C., Prostate cancer screening: issues and controversies Minnesota medicine 2010 93 8 39 44
81. Kalager M., Zelen M., Langmark F., Adami H.-O., Effect of screening mammography on breast-cancer mortality in Norway New England Journal of Medicine 2010 363 13 1203 1210
82. Budd A. C., Sturrock C. J., Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination Sexual Health 2010 7 3 328 334
83. Marchionda P. J., Krause L. K., Jensen J. D., Dellavalle R. P., A North American perspective on dermoscopy: benefits, limitations, and grey zones Giornale Italiano di Dermatologia e Venereologia 2010 145 1 89 97
84. Fert C., Penel N., Bonneterre J., Adenis A., Individual life expectancy estimation using validated prognostic scores for patients with cancer of unknown primary Oncology 2010 78 2 87 93
85. Barros F. F. T., Powe D. G., Ellis I. O., Green A. R., Understanding the HER family in breast cancer: interaction with ligands, dimerization and treatments Histopathology 2010 56 5 560 572
86. Ton C. C., Vartanian N., Chai X., Lin M. G., Yuan X., Malone K. E., Li C. I., Dawson A., Sather C., Delrow J., Hsu L., Porter P. L., Gene expression array testing of FFPE archival breast tumor samples: an optimized protocol for WG-DASL sample preparation. Breast Cancer Research and Treatment. In press
87. Tureci O., Sahin U., Schobert I., Koslowski M., Schmitt H., Schild H. J., Stenner F., Seitz G., Rammensee H. G., Pfreundschuh M., The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40 Cancer Research 1996 56 20 4766 4772 (Pubitemid 26338082)
88. Chen Y. T., Gre A. O., Tsang S., Stockert E., Jger E., Knuth A., Old L. J., Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library Proceedings of the National Academy of Sciences of the United States of America 1998 95 12 6919 6923 (Pubitemid 28278082